Medicine for treating chronic renal insufficiency and chronic renal failure diseases

A technology for renal function and renal failure, which is applied in drug combinations, metabolic diseases, and pharmaceutical formulations, can solve the problems of chronic renal failure, such as ineffective treatment, high mental stress, and heavy economic burden, and restore renal function , The patient's economic burden is light, and the effect of solving pain

Active Publication Date: 2015-04-29
李祖望
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] The technical problem to be solved by the present invention is to provide a drug for treating chronic renal insufficiency and chronic renal failure, aiming at the problems existing in the prior art: for example, th

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating chronic renal insufficiency and chronic renal failure diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] A medicine for treating chronic renal insufficiency and chronic renal failure, comprising the following raw materials in parts by weight: velvet antler 70-90, Fupian 17-23, cassia twig 70-90, cistanche 170-230.

[0063] In the preferred scheme, also include the following raw materials recorded in parts by weight:

[0064] Cornus officinalis 170~230, Rehmannia glutinosa 85~115, Atractylodes macrocephala 170~230, Angelica 170~230, Astragalus 45~55.

[0065] In the preferred scheme, also include the following raw materials recorded in parts by weight:

[0066] Poria 170~230, Qianren 170~230, Paeonol 17~23.

[0067] In the preferred scheme, also include the following raw materials recorded in parts by weight:

[0068] Achyranthes bidentata 85~115, Rhubarb 45~55, Qianren 85~115.

Embodiment 2

[0070] On the basis of Example 1, a kind of medicine for the treatment of chronic renal insufficiency and chronic renal failure, in a further preferred scheme, includes the following raw materials in parts by weight:

[0071] Antler 70, Fu Pian 17, Guizhi 70, Cistanche 170, Dogwood 170, Rehmannia glutinosa 85, Atractylodes macrocephala 170, Angelica 170, Astragalus 45, Poria cocos 170, Qianren 170, Dan bark 17, Achyranthes bidentata 85, Rhubarb 45.

Embodiment 3

[0073] On the basis of Example 1, a kind of medicine for the treatment of chronic renal insufficiency and chronic renal failure, in a further preferred scheme, includes the following raw materials in parts by weight:

[0074] Antler 75, Fupian 18, Guizhi 85, Cistanche 225, Cornus officinalis 210, Rehmannia glutinosa 105, Atractylodes macrocephala 180, Angelica 210, Astragalus 51, Poria cocos 185, Qianren 205, Dan bark 19, Achyranthes bidentata 105, Rhubarb 52.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating chronic renal insufficiency and chronic renal failure diseases. The medicine comprises the following raw materials in parts by weight: 70-90 parts of hairy antler, 17-23 parts of prepared common monkshood daughter root, 70-90 parts of cassia twig and 170-230 parts of all-grass of desertliving cistanche; preferably, the medicine also comprises the following raw materials in parts by weight: 170-230 parts of common macrocarpium fruit, 85-115 parts of prepared rhizome of rehmannia, 170-230 parts of largehead atractylodes rhizome, 170-230 parts of Chinese angelica and 45-55 parts of astragalus membranaceus; preferably, the medicine also comprises the following raw materials in parts by weight: 170-230 parts of Indian buead, 170-230 parts of plantain seed and 17-23 parts of root-bark of tree peony; and preferably, the medicine also comprises the following raw materials in parts by weight: 85-115 parts of twotooth achyranthes root and 45-55 parts of rheum rhabarbarum. The medicine disclosed by the invention can be used for tonifying the kidney-qi, strengthening the kidney-yang and recovering the renal functions, and can be used for treating chronic renal insufficiency, chronic renal failure, limb weakness, waist-knee-limb coldness, difficult urination, frequent urination or nighttime micturition, bleak or dark complexion, sluggish in facial expression, double-limb pitting edema, face and eye edema, urea nitrogen increase, creatinine increase, hypertensive nephropathy and diabetic nephropathy caused by insufficiency of kidney-yang, and treating the chronic renal insufficiency and chronic renal failure diseases caused by medicine injury or other reasons.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating chronic renal insufficiency and chronic renal failure. Background technique [0002] Renal insufficiency (renal insufficiency) is caused by a variety of reasons, and its symptoms are severe damage to the glomerulus, making the body excrete metabolic waste and regulate water, electrolytes, acid-base balance and other aspects of the clinical syndrome. Divided into acute renal insufficiency and chronic renal insufficiency. The prognosis is seriously poor, and it is one of the major diseases that threaten human life. [0003] Among them, chronic renal insufficiency is the final result of various progressive renal diseases. In western medicine, its cause is analyzed as: [0004] 1. Chronic glomerulonephritis. Such as IGA nephropathy, membranous proliferative glomerulonephritis; focal segmental sclerosing glomerulonephritis and mesangial prolifera...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/714A61K36/804A61P13/12A61P9/12A61P3/10A61K35/32
Inventor 李祖望李博文
Owner 李祖望
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products